Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-12 SCHENK LYNN Director Grant or award +880 7,909
2018-06-12 SHERWIN STEPHEN A Director Grant or award +880 6,014
2018-06-01 Ehlers Michael D EVP, Research and Development Shares withheld for taxes −460 $297.09 $137K 4,513.17
2018-06-01 Ehlers Michael D EVP, Research and Development Option exercise +1,384 5,897.17
2018-06-01 Ehlers Michael D EVP, Research and Development Shares withheld for taxes −616 $297.09 $183K 5,281.17
2018-06-01 Ehlers Michael D EVP, Research and Development Option exercise · Restricted Stock Unit −1,384 3,612
2018-06-01 Ehlers Michael D EVP, Research and Development Other disposition · Restricted Stock Unit −1,110 2,502
2018-05-02 Vounatsos Michel Chief Executive Officer Option exercise +1,687 10,118.27
2018-05-02 Vounatsos Michel Chief Executive Officer Shares withheld for taxes −750 $274.13 $206K 9,368.27
2018-05-02 Vounatsos Michel Chief Executive Officer Option exercise · Restricted Stock Unit −1,687 4,809
2018-05-02 Vounatsos Michel Chief Executive Officer Other disposition · Restricted Stock Unit −1,557 3,252
2018-04-25 DENNER ALEXANDER J Director Purchase +48,000 $269.91 $13.0M 461,858
2018-03-01 McKenzie Paul EVP Pharmaceutical Oper & Tech Shares withheld for taxes −405 $282.35 $114K 4,006.82
2018-03-01 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise +532 4,538.82
2018-03-01 McKenzie Paul EVP Pharmaceutical Oper & Tech Shares withheld for taxes −237 $282.35 $67K 4,301.82
2018-03-01 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise · Restricted Stock Unit −532 1,160
2018-03-01 McKenzie Paul EVP Pharmaceutical Oper & Tech Other disposition · Restricted Stock Unit −312 848
2018-03-01 COVINO GREGORY F VP, Chief Accounting Officer Grant or award · Restricted Stock Unit +531 531
2018-02-27 Sandrock Alfred EVP, Chief Medical Officer Sale −259 $290.83 $75K 6,553.38
2018-02-23 Sandrock Alfred EVP, Chief Medical Officer Sale −908 $293.44 $266K 6,553.38

Page 56 of 61 · 1,204 trades